Tag: FDA complex drugs
Complex Generic Formulations: Why Proving Bioequivalence Is Harder Than You Think
Barbara Lalicki
May 21, 2026
Medications
0 Comments
Explore why complex generic formulations face unique hurdles in proving bioequivalence, from local drug delivery challenges to regulatory gaps and new scientific solutions.
read more
